Perspective Therapeutics (STU:AAJ0) Tax Rate %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:AAJ0 Perspective Therapeutics Inc STU:AAJ0
35 GF Score
Price €2.69
GF Value €0.68
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Perspective Therapeutics Tax Rate %?

Perspective Therapeutics STU:AAJ0 +1.13% 35 Tax Rate % is 0.00% as of Jun. 2026. GuruFocus rates STU:AAJ0 with a GF Score™ of 35/100 and a GF Value™ of €0.68 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Perspective Therapeutics's Tax Expense for the three months ended in Jun. 2026 was €0.00 Mil. Perspective Therapeutics's Pre-Tax Income for the three months ended in Jun. 2026 was €-23.42 Mil. Therefore, Perspective Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 was 0.00%.

Perspective Therapeutics Tax Rate % Related Terms

Perspective Therapeutics Tax Rate % Historical Data

* Premium members only.

The historical data trend for Perspective Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics Tax Rate % Chart

Perspective Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 6.61 2.61 0.76

Perspective Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:AAJ0
35GF Score
Perspective Therapeutics Inc STU:AAJ0
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perspective Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Perspective Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=-0.677/-89.182
=0.76 %

Perspective Therapeutics's Tax Rate % for the quarter that ended in Jun. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Jun. 2026 )/Pre-Tax Income (Q: Jun. 2026 )
=0/-23.421
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 0.00% mean?
Perspective Therapeutics (STU:AAJ0) has a Tax Rate % of 0.00% as of Jun. 2026.
Is Perspective Therapeutics' Tax Rate % too high?
Perspective Therapeutics' current Tax Rate % is 0.00%. Overall, Perspective Therapeutics has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' Tax Rate % compare to VMD and MOBI?
Perspective Therapeutics' Tax Rate % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Medical Devices & Instruments company?
A good Tax Rate % depends on the Medical Devices & Instruments industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. Perspective Therapeutics's current Tax Rate % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Based on GuruFocus' analysis, Perspective Therapeutics (STU:AAJ0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.68, compared to a current price of €2.69 — trading 295.3% above its estimated fair value. The current Tax Rate % is 0.00%. Perspective Therapeutics' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For Perspective Therapeutics (STU:AAJ0), the current Tax Rate % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perspective Therapeutics (STU:AAJ0) Overvalued in 2026?

Based on GuruFocus' analysis, Perspective Therapeutics stock appears to be overvalued. The current stock price of €2.69 is trading 295.3% above its estimated GF Value™ of €0.68. GuruFocus considers Perspective Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:AAJ0:

  • Tax Rate %: 0.00%
  • GF Value™: €0.68 vs. price of €2.69 (295.3% above fair value)
  • GF Score™: 35/100 with 2 warning signs

No single metric tells the full story. See the STU:AAJ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perspective Therapeutics Business Description

Other Exchanges CATX:USAAAJ0:Germany
Address 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
35GF Score

Get the complete analysis for STU:AAJ0

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.69
Price
€0.68
GF Value